Pulmonary toxoplasmosis, a rare but severe manifestation of a common opportunistic infection in late HIV presenters: Report of two cases

Infection

Volumn 38, Issue 2, 2010, Pages 141-144

  Kovari, H ^a   Ebnother C ^b   Schweiger, A ^c   Berther, N ^a   Kuster, H ^a   Gunthard H F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATOVAQUONE; C REACTIVE PROTEIN; CLARITHROMYCIN; COTRIMOXAZOLE; FOLINIC ACID; HEMOGLOBIN; LACTATE DEHYDROGENASE; PREDNISONE; PYRIMETHAMINE; SULFADIAZINE;

ADULT; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATAXIA; BACTERIAL PNEUMONIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE COURSE; DRUG MEGADOSE; DYSARTHRIA; DYSPNEA; FEVER; FUNGAL DETECTION; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG ABSCESS; LUNG EDEMA; LUNG INFILTRATE; LUNG LAVAGE; LYMPHADENOPATHY; LYMPHOCYTOPENIA; LYMPHOMA; MALAISE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PROTEIN BLOOD LEVEL; PULMONARY TOXOPLASMOSIS; RARE DISEASE; RESPIRATORY DISTRESS SYNDROME; THORAX PAIN; THORAX RADIOGRAPHY; TOXOPLASMA GONDII; TOXOPLASMOSIS; WEIGHT REDUCTION; WHEEZING;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIPROTOZOAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; LUNG DISEASES; MALE; MICROSCOPY; RADIOGRAPHY, THORACIC; RNA, VIRAL; TOMOGRAPHY; TOXOPLASMOSIS; TREATMENT OUTCOME;

EID: 77953229082     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-009-9367-5     Document Type: Article

References (19)

1. Antiretroviral Therapy Cohort Collaboration 2008 Life expectancy of individuals on combination antiretroviral therapy in highincome countries: a collaborative analysis of 14 cohort studies Lancet 372 293 299 10.1016/S0140-6736(08)61113-7 (Pubitemid 352020438)
2. M. Egger B. Hirschel P. Francioli P. Sudre M. Wirz M. Flepp M. Rickenbach R. Malinverni P. Vernazza M. Battegay 1997 Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study BMJ 315 1194 1199 1:STN:280: DyaK1c%2FlsV2gsw%3D%3D 9393221
3. F.J. Palella Jr K.M. Delaney A.C. Moorman M.O. Loveless J. Fuhrer G.A. Satten D.J. Aschman S.D. Holmberg 1998 Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N Engl J Med 338 853 860 10.1056/NEJM199803263381301 9516219 (Pubitemid 28135961)
4. C.A. Sabin C.J. Smith H. Gumley G. Murphy F.C. Lampe A.N. Phillips B. Prinz M. Youle M.A. Johnson 2004 Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy AIDS 18 2145 2151 10.1097/00002030-200411050-00006 15577647 (Pubitemid 39463679)
5. M. Battegay U. Fluckiger B. Hirschel H. Furrer 2007 Late presentation of HIV-infected individuals Antivir Ther 12 841 851 17926639
6. E. Girardi C.A. Sabin A.D. Monforte 2007 Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing J Acquir Immune Defic Syndr 46 Suppl1 S3 S8 17713423
7. S.B. Porter M.A. Sande 1992 Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome N Engl J Med 327 1643 1648 1:STN:280:DyaK3s%2FmtlSruw%3D%3D 1359410
8. E. Oksenhendler J. Cadranel C. Sarfati C. Katlama A. Datry C. Marche M. Wolf P. Roux F. Derouin J.P. Clauvel 1990 Toxoplasma gondii pneumonia in patients with the acquired immunodeficiency syndrome Am J Med 88 18N 21N 1:STN:280:DyaK3czhtlOrtg%3D%3D 2368769
9. C. Rabaud T. May C. Amiel C. Katlama C. Leport P. Ambroise-Thomas P. Canton 1994 Extracerebral toxoplasmosis in patients infected with HIV. A French National Survey Medicine (Baltimore) 73 306 314 1:STN:280:DyaK2M%2FnsFartg%3D%3D
10. D.E. Eza S.B. Lucas 2006 Fulminant toxoplasmosis causing fatal pneumonitis and myocarditis HIV Med 7 415 420 10.1111/j.1468-1293.2006.00393.x 1:STN:280:DC%2BD28rgvVOjsA%3D%3D 16903988 (Pubitemid 44123254)
11. L. Signorini M. Gulletta D. Coppini C. Donzelli R. Stellini N. Manca G. Carosi A. Matteelli 2007 Fatal disseminated toxoplasmosis during primary HIV infection Curr HIV Res 5 273 274 10.2174/157016207780077011 1:CAS:528: DC%2BD2sXjsF2qtrY%3D 17346141 (Pubitemid 46488203)
12. J.F. Murray C.P. Felton S.M. Garay M.S. Gottlieb P.C. Hopewell D.E. Stover A.S. Teirstein 1984 Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop N Engl J Med 310 1682 1688 1:STN:280:DyaL2c3hvFKisA%3D%3D 6328301
13. S. Gandhi S. Lyubsky V. Jimenez-Lucho 1994 Adult respiratory distress syndrome associated with disseminated toxoplasmosis Clin Infect Dis 19 169 171 1:STN:280:DyaK2M%2FjsFKiug%3D%3D 7948525
14. C. Rabaud T. May J.C. Lucet C. Leport P. Ambroise-Thomas P. Canton 1996 Pulmonary toxoplasmosis in patients infected with human immunodeficiency virus: a French National Survey Clin Infect Dis 23 1249 1254 1:STN:280: DyaK2s7htFWqtw%3D%3D 8953067
15. J.A. Sterne M.A. Hernán B. Ledergerber K. Tilling R. Weber P. Sendi M. Rickenbach J.M. Robins M. Egger Swiss HIV Cohort Study 2005 Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study Lancet 366 378 384 10.1016/S0140-6736(05)67022-5 1:CAS:528:DC%2BD2MXmvVWmsbc%3D 16054937 (Pubitemid 41073955)
16. C. Pomeroy G.A. Filice 1992 Pulmonary toxoplasmosis: a review Clin Infect Dis 14 863 870 1:STN:280:DyaK383ksl2rtw%3D%3D 1576281
17. J. Pugin P. Vanhems B. Hirschel J.P. Chave M. Flepp 1992 Extreme elevations of serum lactic dehydrogenase differentiating pulmonary toxoplasmosis from pneumocystis pneumonia N Engl J Med 326 1226 1:STN:280: DyaK383ht1Ciuw%3D%3D 1557107
18. F. Belanger F. Derouin L. Grangeot-Keros L. Meyer 1999 Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995. HEMOCO and SEROCO Study Groups Clin Infect Dis 28 575 581 10.1086/515147 1:STN:280:DyaK1M3gvVChtg%3D%3D 10194081
19. S.B. Lucas A. Hounnou C. Peacock A. Beaumel G. Djomand J.M. N'Gbichi K. Yeboue M. Hondé M. Diomande C. Giordano R. Doorly K. Brattegaard L. Kestens R. Smithwick A. Kadio N. Ezani A. Yapi K.M. De Cock 1993 The mortality and pathology of HIV infection in a west African city AIDS 7 1569 1579 10.1097/00002030-199312000-00005 1:STN:280:DyaK2c7hsVWgsg%3D%3D 7904450